Literature DB >> 15930516

ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile.

Silvia Langheim1, Liqing Yu, Klaus von Bergmann, Dieter Lütjohann, Fang Xu, Helen H Hobbs, Jonathan C Cohen.   

Abstract

The major pathway for the removal of cholesterol from the body is via secretion into the bile. Three members of the ATP binding cassette (ABC) family, ABCG5 (G5), ABCG8 (G8), and ABCB4 (MDR2), are required for the efficient biliary export of sterols. Here, we examined the interdependence of these three ABC transporters for biliary sterol secretion. Biliary lipid levels in mice expressing no MDR2 (Mdr2-/- mice) were compared with those of Mdr2-/- mice expressing 14 copies of a human G5 (hG5) and hG8 transgene (Mdr2-/-;hG5G8Tg mice). Mdr2-/- mice had only trace amounts of biliary cholesterol and phospholipids. The Mdr2-/-;hG5G8Tg mice had biliary cholesterol levels as low as those of Mdr2-/- mice. Thus, MDR2 expression is required for G5G8-mediated biliary sterol secretion. To determine whether the reduction in fractional absorption of dietary sterols associated with G5G8 overexpression is secondary to the associated increase in biliary cholesterol, we compared the fractional absorption of sterols in Mdr2-/-;hG5G8Tg and hG5G8Tg animals. Inactivation of MDR2 markedly attenuated the reduction in fractional sterol absorption associated with G5G8 overexpression. These results are consistent with the notion that increased biliary cholesterol secretion contributes to the reduction in fractional sterol absorption associated with G5G8 overexpression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930516     DOI: 10.1194/jlr.M500115-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  33 in total

1.  ABCB4 mediates diet-induced hypercholesterolemia in laboratory opossums.

Authors:  Jeannie Chan; Michael C Mahaney; Rampratap S Kushwaha; Jane F VandeBerg; John L VandeBerg
Journal:  J Lipid Res       Date:  2010-05-20       Impact factor: 5.922

Review 2.  Emerging roles of the intestine in control of cholesterol metabolism.

Authors:  Janine-K Kruit; Albert K Groen; Theo J van Berkel; Folkert Kuipers
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

3.  Complementary Cholesterol-Lowering Response of a Phytosterol/α-Lipoic Acid Combination in Obese Zucker Rats.

Authors:  Todd C Rideout; Bradley Carrier; Shin Wen; Amy Raslawsky; Richard W Browne; Scott V Harding
Journal:  J Diet Suppl       Date:  2015-02-09

4.  Infection of primary hepatocytes with adenoviral vectors alters biliary lipid metabolism.

Authors:  Yuri Rueda; Itsaso Garcia-Arcos; Patricia Aspichueta; Begoña Ochoa; Lourdes Palacios; Olatz Fresnedo
Journal:  J Physiol Sci       Date:  2013-04-05       Impact factor: 2.781

Review 5.  The ABCG family of membrane-associated transporters: you don't have to be big to be mighty.

Authors:  Ian D Kerr; Ameena J Haider; Ingrid C Gelissen
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 6.  Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.

Authors:  Helen H Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 7.  ABCG transporters: structure, substrate specificities and physiological roles : a brief overview.

Authors:  Saroj Velamakanni; Shen L Wei; Tavan Janvilisri; Hendrik W van Veen
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

Review 8.  ABCG5 and ABCG8: more than a defense against xenosterols.

Authors:  Shailendra B Patel; Gregory A Graf; Ryan E Temel
Journal:  J Lipid Res       Date:  2018-05-04       Impact factor: 5.922

Review 9.  Nuclear receptors in bile acid metabolism.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

10.  Regulation of bile acid and cholesterol metabolism by PPARs.

Authors:  Tiangang Li; John Y L Chiang
Journal:  PPAR Res       Date:  2009-07-14       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.